SOX2 and colorectal carcinoma: Data showed that SOX2 expression was not correlated with cancer-specific survival (CSS) of CRC in three studies with 855 patients (HR = 1.18, P=0.667) (Figure 4) but was correlated with worse overall survival (OS) in two studies with 536 patients (P < 0.05) [24, 34].